519 related articles for article (PubMed ID: 33741405)
41. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS
Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
[TBL] [Abstract][Full Text] [Related]
42. Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae.
Achenbach JC; Hill J; Hui JPM; Morash MG; Berrue F; Ellis LD
Zebrafish; 2018 Aug; 15(4):349-360. PubMed ID: 29634460
[TBL] [Abstract][Full Text] [Related]
43. Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain.
Abraham AD; Leung EJY; Wong BA; Rivera ZMG; Kruse LC; Clark JJ; Land BB
Neuropsychopharmacology; 2020 Jun; 45(7):1105-1114. PubMed ID: 31812152
[TBL] [Abstract][Full Text] [Related]
44. Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.
Hernán Pérez de la Ossa D; Lorente M; Gil-Alegre ME; Torres S; García-Taboada E; Aberturas Mdel R; Molpeceres J; Velasco G; Torres-Suárez AI
PLoS One; 2013; 8(1):e54795. PubMed ID: 23349970
[TBL] [Abstract][Full Text] [Related]
45. Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment.
Zubcevic K; Petersen M; Bach FW; Heinesen A; Enggaard TP; Almdal TP; Holbech JV; Vase L; Jensen TS; Hansen CS; Finnerup NB; Sindrup SH
Eur J Pain; 2023 Apr; 27(4):492-506. PubMed ID: 36571471
[TBL] [Abstract][Full Text] [Related]
46. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment.
Dumbraveanu C; Strommer K; Wonnemann M; Choconta JL; Neumann A; Kress M; Kalpachidou T; Kummer KK
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986714
[TBL] [Abstract][Full Text] [Related]
48. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
49. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
[TBL] [Abstract][Full Text] [Related]
50. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Parker LA; Kwiatkowska M; Burton P; Mechoulam R
Psychopharmacology (Berl); 2004 Jan; 171(2):156-61. PubMed ID: 13680081
[TBL] [Abstract][Full Text] [Related]
51. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
[TBL] [Abstract][Full Text] [Related]
52. Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism.
de Almeida DL; Mendes Ferreira RC; Fonseca FC; Dias Machado DP; Aguiar DD; Guimaraes FS; Duarte IDG; Romero TRL
Nitric Oxide; 2024 May; 146():1-9. PubMed ID: 38428514
[TBL] [Abstract][Full Text] [Related]
53. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
[TBL] [Abstract][Full Text] [Related]
54. Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats.
Gabaglio M; Zamberletti E; Manenti C; Parolaro D; Rubino T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445602
[TBL] [Abstract][Full Text] [Related]
55. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
56. Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol.
Černe K
Arh Hig Rada Toksikol; 2020 Mar; 71(1):1-11. PubMed ID: 32597140
[TBL] [Abstract][Full Text] [Related]
57. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
Martin-Santos R; Crippa JA; Batalla A; Bhattacharyya S; Atakan Z; Borgwardt S; Allen P; Seal M; Langohr K; Farré M; Zuardi AW; McGuire PK
Curr Pharm Des; 2012; 18(32):4966-79. PubMed ID: 22716148
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders.
Fernández-Trapero M; Pérez-Díaz C; Espejo-Porras F; de Lago E; Fernández-Ruiz J
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32054131
[TBL] [Abstract][Full Text] [Related]
59. Subjective and physiological effects after controlled Sativex and oral THC administration.
Karschner EL; Darwin WD; McMahon RP; Liu F; Wright S; Goodwin RS; Huestis MA
Clin Pharmacol Ther; 2011 Mar; 89(3):400-7. PubMed ID: 21289620
[TBL] [Abstract][Full Text] [Related]
60. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
